These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 30400791)
1. The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review. Haeusler IL; Chan XHS; Guérin PJ; White NJ BMC Med; 2018 Nov; 16(1):200. PubMed ID: 30400791 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Randomized Controlled Trial of the Electrocardiographic Effects of Four Antimalarials for Pregnant Women with Uncomplicated Malaria on the Thailand-Myanmar Border. Saito M; Yotyingaphiram W; Cargill Z; Gilder ME; Min AM; Phyo AP; San TD; Poe H; Chu C; White NJ; Nosten F; McGready R Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495217 [TBL] [Abstract][Full Text] [Related]
4. The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis. Chan XHS; Haeusler IL; Win YN; Pike J; Hanboonkunupakarn B; Hanafiah M; Lee SJ; Djimdé A; Fanello CI; Kiechel JR; Lacerda MV; Ogutu B; Onyamboko MA; Siqueira AM; Ashley EA; Taylor WR; White NJ PLoS Med; 2021 Sep; 18(9):e1003766. PubMed ID: 34492005 [TBL] [Abstract][Full Text] [Related]
5. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM; Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078 [TBL] [Abstract][Full Text] [Related]
7. A trial of combination antimalarial therapies in children from Papua New Guinea. Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624 [TBL] [Abstract][Full Text] [Related]
8. Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis. Chan XHS; Win YN; Mawer LJ; Tan JY; Brugada J; White NJ Lancet Infect Dis; 2018 Aug; 18(8):913-923. PubMed ID: 29887371 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228 [TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of antimalarial drugs. White NJ Lancet Infect Dis; 2007 Aug; 7(8):549-58. PubMed ID: 17646028 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data. Chan XHS; Win YN; Haeusler IL; Tan JY; Loganathan S; Saralamba S; Chan SKS; Ashley EA; Barnes KI; Baiden R; Bassi PU; Djimde A; Dorsey G; Duparc S; Hanboonkunupakarn B; Ter Kuile FO; Lacerda MVG; Nasa A; Nosten FH; Onyeji CO; Pukrittayakamee S; Siqueira AM; Tarning J; Taylor WRJ; Valentini G; van Vugt M; Wesche D; Day NPJ; Huang CL; Brugada J; Price RN; White NJ PLoS Med; 2020 Mar; 17(3):e1003040. PubMed ID: 32134952 [TBL] [Abstract][Full Text] [Related]
13. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis. Commons RJ; Simpson JA; Thriemer K; Hossain MS; Douglas NM; Humphreys GS; Sibley CH; Guerin PJ; Price RN Lancet Infect Dis; 2019 Jan; 19(1):91-101. PubMed ID: 30587297 [TBL] [Abstract][Full Text] [Related]
14. Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients. Wu W; Liang Y; Wu G; Su Y; Zhang H; Zhang Z; Deng C; Wang Q; Huang B; Tan B; Zhou C; Song J Rev Soc Bras Med Trop; 2019 May; 52():e20180453. PubMed ID: 31141053 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval. Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702 [TBL] [Abstract][Full Text] [Related]
17. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
18. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial. Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412 [TBL] [Abstract][Full Text] [Related]